{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:21:38Z","timestamp":1772180498187,"version":"3.50.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003661","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T19:35:54Z","timestamp":1225913754000},"page":"e3661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Integrative Genomic Data Mining for Discovery of Potential Blood-Borne Biomarkers for Early Diagnosis of Cancer"],"prefix":"10.1371","volume":"3","author":[{"given":"Yongliang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmanan K.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. James","family":"Adelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin I.","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,11,6]]},"reference":[{"key":"ref1","first-page":"109","article-title":"Identifying markers for pancreatic cancer by gene expression analysis.","volume":"7","author":"W Zhou","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/425905a","article-title":"Clinical proteomics: written in blood.","volume":"425","author":"LA Liotta","year":"2003","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1158\/1078-0432.CCR-05-2081","article-title":"Novel blood biomarkers of human urinary bladder cancer.","volume":"12","author":"I Osman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.","volume":"100","author":"JB Welsh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1196\/annals.1310.005","article-title":"Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.","volume":"1020","author":"DR Rhodes","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2105-7-481","article-title":"Mining expressed sequence tags identifies cancer markers of clinical interest.","volume":"7","author":"F Campagne","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-6-25","article-title":"Contribution of oncoproteomics to cancer biomarker discovery.","volume":"6","author":"WCS Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"ref8","first-page":"247","article-title":"Gene expression assays.","volume":"44","author":"J Kirby","year":"2007","journal-title":"AdvClin Chem"},{"key":"ref9","first-page":"778","article-title":"Microarray data mining using Gene Ontology.","volume":"107","author":"S Li","year":"2004","journal-title":"Medinfo"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/1535-7163.MCT-06-0465","article-title":"<italic>In silico<\/italic> design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase\u2013mediated cancer diagnosis and therapy.","volume":"5","author":"K Chen","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1471-2105-7-354","article-title":"A combined approach to data mining of textual and structured data to identify cancer-related targets.","volume":"7","author":"P Pospisil","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/0008-5472.CAN-06-3309","article-title":"Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.","volume":"67","author":"P Pospisil","year":"2007","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.","volume":"9","author":"DR Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"ref14"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1158\/0008-5472.CAN-05-3433","article-title":"Common cancer biomarkers.","volume":"66","author":"CF Basil","year":"2006","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/bioinformatics\/bti419","article-title":"Multiclass cancer classification and biomarker discovery using GA-based algorithms.","volume":"21","author":"JJ Liu","year":"2005","journal-title":"Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1158\/1078-0432.CCR-03-0200","article-title":"Detection of prostate cancer and predicting progression: current and future diagnostic markers.","volume":"10","author":"JV Tricoli","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2004\/509276","article-title":"Promise and challenge: markers of prostate cancer detection, diagnosis and prognosis.","volume":"20","author":"DA Troyer","year":"2004","journal-title":"Dis Markers"},{"key":"ref19"},{"key":"ref20"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies.","volume":"100","author":"JD Storey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.copbio.2003.12.004","article-title":"Statistical analysis of global gene expression data: some practical considerations.","volume":"15","author":"T Holzman","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"ref24"},{"key":"ref25"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1126\/science.1083158","article-title":"Developing molecular biomarkers for cancer.","volume":"299","author":"DF Ransohoff","year":"2003","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1373\/clinchem.2004.032177","article-title":"How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer.","volume":"50","author":"EP Diamandis","year":"2004","journal-title":"Clin Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1634\/theoncologist.8-4-307","article-title":"The HER-2\/<italic>neu<\/italic> gene and protein in breast cancer 2003: biomarker and target of therapy.","volume":"8","author":"JS Ross","year":"2003","journal-title":"Oncologist"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/ijc.22779","article-title":"Overexpression of <italic>ErbB2<\/italic> in the exocrine pancreas induces an inflammatory response but not increased proliferation.","volume":"121","author":"H Alg\u00fcl","year":"2007","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14737159.3.5.573","article-title":"Breast cancer biomarkers and molecular medicine.","volume":"3","author":"JS Ross","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1158\/0008-5472.CAN-04-2684","article-title":"Altered erbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.","volume":"65","author":"K Macleod","year":"2005","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene <italic>BRCA1<\/italic>.","volume":"266","author":"Y Miki","year":"1994","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2.","volume":"108","author":"AR Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr777","article-title":"Prognostic molecular markers in early breast cancer.","volume":"6","author":"FJ Esteva","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/bgi136","article-title":"<italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> as ovarian cancer susceptibility genes.","volume":"26","author":"HM Sowter","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level \u22644.0 ng per milliliter.","volume":"350","author":"IM Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"ref37","first-page":"2104","article-title":"Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.","volume":"55","author":"H Yu","year":"1995","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/oxfordjournals.jbchem.a021861","article-title":"Isolation and characterization of the plasma hyaluronan-binding protein (PHBP) gene (<italic>HABP2<\/italic>).","volume":"122","author":"J Sumiya","year":"1997","journal-title":"J Biochem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1038\/sj.onc.1205953","article-title":"Novel candidate tumor marker genes for lung adenocarcinoma.","volume":"21","author":"K Wang","year":"2002","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1073\/pnas.96.6.3098","article-title":"Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone <italic>in vitro<\/italic>.","volume":"96","author":"VJ Csernus","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/mp.54.5.285","article-title":"IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?","volume":"54","author":"W Zumkeller","year":"2001","journal-title":"J Clin Pathol Mol Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","article-title":"Serum protein markers for early detetion of ovarian cancer.","volume":"102","author":"G Mor","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/sj.onc.1202600","article-title":"Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine\/paracrine mechanism.","volume":"18","author":"L Sciacca","year":"1999","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","article-title":"Plasma levels of insulin-like growth factor-I and lung cancer risk: a case\u2013control analysis.","volume":"91","author":"H Yu","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"ref45","first-page":"8601","article-title":"Insulin-like growth factor -binding protein-2 in tumorigenesis: protector or promoter?","volume":"61","author":"A Hoeflich","year":"2001","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nbt0305-297","article-title":"In biomarkers we trust?","volume":"23","author":"M Baker","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00941802","article-title":"Detection of matrix metalloproteinase activity in human pancreatic cancer.","volume":"27","author":"T Koshiba","year":"1997","journal-title":"Surg Today"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.0.CO;2-O","article-title":"Role of MT-MMPs and MMP-2 in pancreatic cancer progression.","volume":"85","author":"V Ellenrieder","year":"2000","journal-title":"Int J Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF02574483","article-title":"Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.","volume":"9","author":"M Bloomston","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I","article-title":"Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse -and intestinal-type gastric carcinoma.","volume":"84","author":"T Migita","year":"1999","journal-title":"Int J Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1158\/1055-9965.EPI-04-0482","article-title":"Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.","volume":"14","author":"L Su","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1634\/theoncologist.5-2-108","article-title":"MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer.","volume":"5","author":"E Sunami","year":"2000","journal-title":"Oncologist"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.bjc.6690633","article-title":"Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.","volume":"80","author":"D Masson","year":"1999","journal-title":"Br J Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1158\/0008-5472.CAN-04-0202","article-title":"Hyaluronan facilitates invasion of colon carcinoma cells <italic>in vitro<\/italic> via interaction with CD44.","volume":"64","author":"H-R Kim","year":"2004","journal-title":"Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"46896","DOI":"10.1074\/jbc.M108451200","article-title":"Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocystine-cystine-mixed disulfide, and cystine in circulation.","volume":"276","author":"S Sengupta","year":"2001","journal-title":"J Biol Chem"},{"key":"ref56","first-page":"3869","article-title":"Coordinately up-regulated genes in ovarian cancer.","volume":"61","author":"CD Hough","year":"2001","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1535-6108(03)00140-5","article-title":"Notch mediates TGFa-induced changes in epithelial differentiation during pancreatic tumorigenesis.","volume":"3","author":"Y Miyamoto","year":"2003","journal-title":"Cancer Cell"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/jnci\/djm148","article-title":"<italic>Arrested development?<\/italic> Notch emerges as new cancer drug target.","volume":"99","author":"K Garber","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1038\/sj.onc.1205570","article-title":"Expression profiling of microdissected pancreatic adenocarcinomas.","volume":"21","author":"T Crnogorac-Jurcevic","year":"2002","journal-title":"Oncogene"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/CBM-2006-23-404","article-title":"Genomic approach to biomarker identification and its recent applications.","volume":"2","author":"YD He","year":"2006","journal-title":"Cancer Biomark"}],"updated-by":[{"DOI":"10.1371\/annotation\/9fbf88b3-5041-4a5e-b569-bc6c0e5f9c29","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T00:00:00Z","timestamp":1232928000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T09:34:31Z","timestamp":1738488871000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003661"}},"subtitle":[],"editor":[{"given":"Oliver","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,11,6]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003661","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1128805.585886","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,6]]}}}